These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 6617728)

  • 21. Pharmacokinetics of canrenone after oral administration of spironolactone and intravenous injection of canrenoate-K in healthy man.
    Krause W; Karras J; Seifert W
    Eur J Clin Pharmacol; 1983; 25(4):449-53. PubMed ID: 6653638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of oral and intravenous fluorouracil in humans.
    Phillips TA; Howell A; Grieve RJ; Welling PG
    J Pharm Sci; 1980 Dec; 69(12):1428-31. PubMed ID: 7463330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. L-arginine-induced vasodilation in healthy humans: pharmacokinetic-pharmacodynamic relationship.
    Bode-Böger SM; Böger RH; Galland A; Tsikas D; Frölich JC
    Br J Clin Pharmacol; 1998 Nov; 46(5):489-97. PubMed ID: 9833603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of ipratropium bromide after single dose inhalation and oral and intravenous administration.
    Ensing K; de Zeeuw RA; Nossent GD; Koëter GH; Cornelissen PJ
    Eur J Clin Pharmacol; 1989; 36(2):189-94. PubMed ID: 2524387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioavailability of dihydroergotamine in man.
    Little PJ; Jennings GL; Skews H; Bobik A
    Br J Clin Pharmacol; 1982 Jun; 13(6):785-90. PubMed ID: 7093108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of metformin after intravenous and oral administration to man.
    Pentikäinen PJ; Neuvonen PJ; Penttilä A
    Eur J Clin Pharmacol; 1979 Sep; 16(3):195-202. PubMed ID: 499320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of the new analgesic, meptazinol, after oral and intravenous administration to volunteers.
    Norbury HM; Franklin RA; Graham DF
    Eur J Clin Pharmacol; 1983; 25(1):77-80. PubMed ID: 6617729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ketanserin, a novel 5-hydroxytryptamine antagonist: monotherapy in essential hypertension.
    Hedner T; Persson B; Berglund G
    Br J Clin Pharmacol; 1983 Aug; 16(2):121-5. PubMed ID: 6615685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of ketanserin on phenylephrine-dependent changes in splanchnic hemodynamics and systemic blood pressure in healthy subjects.
    Gasic S; Eichler HG; Korn A
    J Cardiovasc Pharmacol; 1985; 7(2):219-23. PubMed ID: 2581071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ketanserin in combination with beta-adrenergic receptor blocking agents in the treatment of essential hypertension.
    Hedner T; Persson B
    Br J Clin Pharmacol; 1984 Nov; 18(5):765-71. PubMed ID: 6150724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ranitidine bioavailability and kinetics in normal male subjects.
    Garg DC; Weidler DJ; Eshelman FN
    Clin Pharmacol Ther; 1983 Apr; 33(4):445-52. PubMed ID: 6299642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of xamoterol after intravenous and oral administration to patients with chronic heart failure.
    Sorensen EV; Faergeman O; Day M; Bastain W
    Eur J Clin Pharmacol; 1988; 35(2):183-5. PubMed ID: 2903827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor 2,2,2-trifluoro-1-(3-trimethylsilylphenyl) ethanone in dog. Potential for transdermal patch delivery.
    Dow J; Dulery BD; Hornsperger JM; Di Francesco GF; Keshary P; Haegele KD
    Arzneimittelforschung; 1995 Dec; 45(12):1245-52. PubMed ID: 8595078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Absolute oral bioavailability of traxoprodil in cytochrome P450 2D6 extensive and poor metabolisers.
    Taylor TJ; Diringer K; Russell T; Venkatakrishnan K; Wilner K; Crownover PH; Benincosa LJ; Gibbs MA
    Clin Pharmacokinet; 2006; 45(10):989-1001. PubMed ID: 16984212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of ketanserin in patients with cirrhosis.
    Lebrec D; Hadengue A; Gaudin C; Levron JC; Fraitag B; Berthelot P; Benhamou JP
    Clin Pharmacokinet; 1990 Aug; 19(2):160-6. PubMed ID: 2379381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of ketoprofen after multiple intravenous doses to mares.
    Sams R; Gerken DF; Ashcraft SM
    J Vet Pharmacol Ther; 1995 Apr; 18(2):108-16. PubMed ID: 7629924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imipramine disposition in users of oral contraceptive steroids.
    Abernethy DR; Greenblatt DJ; Shader RI
    Clin Pharmacol Ther; 1984 Jun; 35(6):792-7. PubMed ID: 6734030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioavailability and pharmacokinetics of ketanserin in elderly subjects.
    Kurowski M
    Eur J Clin Pharmacol; 1985; 28(4):411-7. PubMed ID: 3161741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of famotidine in man.
    Kroemer H; Klotz U
    Int J Clin Pharmacol Ther Toxicol; 1987 Aug; 25(8):458-63. PubMed ID: 2888738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma pharmacokinetics and tissue distribution of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) in CD2F1 mice1.
    Egorin MJ; Zuhowski EG; Rosen DM; Sentz DL; Covey JM; Eiseman JL
    Cancer Chemother Pharmacol; 2001 Apr; 47(4):291-302. PubMed ID: 11345645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.